MAKING CANCER MORE CURABLE
TOGETHER
NEWS
Merger between TTFactor and Cogentech Società Benefit a r.l.
Dear Customers and Suppliers,
We would like to inform you that as of January 1, 2023, the merger between TTFactor and Cogentech Società Benefit a r.l. has been completed.
As a result of this merger, we hereby inform you that Cogentech has fully absorbed the operations of TTFactor.
Therefore, we would like to communicate that all matters related to technology transfer activities should now be directed
to the Technology Transfer Office of IFOM (IFOM TTO) at the following address:
IFOM ETS, AIRC Institute of Molecular Oncology
Technology Transfer Office (IFOM TTO)
Via Adamello, 16
20139 Milan (MI)
Italy
Specifically, email communications should be sent to the following address: tto-team[@]ifom.eu.
We would like to express our gratitude for the trust and support you have bestowed upon us over the years, and we look forward to continuing our productive collaboration in the future.
Should you require any further information or clarification, please do not hesitate to contact us.
DOWNLOADS
Relazione di Impatto 2022
Relazione di Impatto 2021
Relazione di Impatto 2020
CONTACTS & DIRECTIONS
Address: Via Adamello, 16 – 20139 Milan (Italy)
Phone: +39 02 574 303 200
Business hours: 9h00 – 18h00 (Monday – Friday)